Less than 2% of artificial intelligence devices authorized by the US Food and Drug Agency are prognostic, with prediction horizons ranging from minutes to several years. As the number of prognostic AI devices could increase, it is important to address the accompanying regulatory and ethical challenges.
- Urs J. Muehlematter
- Kerstin Noelle Vokinger
